Transforming growth factor-β (TGF-β) secreted by CAFs limits T cell infiltration into the tumor (39) while also downregulating the expression of MHC-II, CD80, and CD40 on the surface of dendritic cells in the TME, suppressing anti-tumor immunity (40). This evidence concerns the gene TGFB1 and neoplasm.